{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:58:23Z","timestamp":1790870303648,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":51,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-42656-z","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T08:34:03Z","timestamp":1776155643000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Integrated computational screening of FDA-approved anticancer drugs as novel HPV-16 E6 inhibitors in cervical cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Mahshid","family":"Ahmadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Yoosefian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"issue":"1","key":"42656_CR1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.antiviral.2006.03.014","volume":"72","author":"JD Baleja","year":"2006","unstructured":"Baleja, J. D. et al. Identification of inhibitors to papillomavirus type 16 E6 protein based on three-dimensional structures of interacting proteins. Antiviral Res. 72 (1), 49\u201359 (2006).","journal-title":"Antiviral Res."},{"key":"42656_CR2","doi-asserted-by":"crossref","unstructured":"Datta, A. et al. Impact of hypoxia on cervical cancer outcomes. Int. J. Gynecol. Cancer 31(11), 1459\u20131470 (2021).","DOI":"10.1136\/ijgc-2021-002806"},{"key":"42656_CR3","doi-asserted-by":"publisher","first-page":"115443","DOI":"10.1016\/j.jphotochem.2023.115443","volume":"450","author":"L Montazer","year":"2024","unstructured":"Montazer, L. et al. Carbon quantum dots and gold nanostructures on photothermal therapy for cancer treatment. J. Photochem. Photobiol., A. 450, 115443 (2024).","journal-title":"J. Photochem. Photobiol., A"},{"key":"42656_CR4","doi-asserted-by":"crossref","unstructured":"Chen, S. et al. YTHDC1 inhibits cell proliferation and angiogenesis in cervical cancer by regulating m6A modification of SOCS4 mRNA Vol. 20, p. 533\u2013540 (Molecular & Cellular Toxicology, 2024). 3.","DOI":"10.1007\/s13273-023-00360-3"},{"key":"42656_CR5","doi-asserted-by":"publisher","first-page":"119126","DOI":"10.1016\/j.jep.2024.119126","volume":"338","author":"J Zhou","year":"2025","unstructured":"Zhou, J. et al. Chrysotoxine regulates ferroptosis and the PI3K\/AKT\/mTOR pathway to prevent cervical cancer. J. Ethnopharmacol. 338, 119126 (2025).","journal-title":"J. Ethnopharmacol."},{"issue":"5","key":"42656_CR6","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1515\/hsz-2019-0408","volume":"401","author":"O Basukala","year":"2020","unstructured":"Basukala, O., Sarabia-Vega, V. & Banks, L. Human papillomavirus oncoproteins and post-translational modifications: generating multifunctional hubs for overriding cellular homeostasis. Biol. Chem. 401 (5), 585\u2013599 (2020).","journal-title":"Biol. Chem."},{"issue":"7587","key":"42656_CR7","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nature16481","volume":"529","author":"D Martinez-Zapien","year":"2016","unstructured":"Martinez-Zapien, D. et al. Structure of the E6\/E6AP\/p53 complex required for HPV-mediated degradation of p53. Nature 529 (7587), 541\u2013545 (2016).","journal-title":"Nature"},{"key":"42656_CR8","first-page":"157","volume":"77","author":"A Esmaeili","year":"2023","unstructured":"Esmaeili, A., Yoosefian, M. & Mahani, M. Molecular Dynamics simulation of lenalidomide interaction with cRBN Protein: a target for immunomodulatory Drugs. S. Afr. J. Chem. 77, 157\u2013162 (2023).","journal-title":"S. Afr. J. Chem."},{"issue":"5","key":"42656_CR9","doi-asserted-by":"publisher","first-page":"051701","DOI":"10.3788\/COL202018.051701","volume":"18","author":"X Ma","year":"2020","unstructured":"Ma, X. et al. Detection of breast cancer based on novel porous silicon Bragg reflector surface-enhanced Raman spectroscopy-active structure. Chin. Opt. Lett. 18 (5), 051701 (2020).","journal-title":"Chin. Opt. Lett."},{"issue":"5","key":"42656_CR10","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/cncr.34617","volume":"129","author":"SE Podwika","year":"2023","unstructured":"Podwika, S. E. & Duska, L. R. Top advances of the year: cervical cancer. Cancer 129 (5), 657\u2013663 (2023).","journal-title":"Cancer"},{"issue":"2","key":"42656_CR11","first-page":"190","volume":"14","author":"H van Meir","year":"2014","unstructured":"van Meir, H. et al. The need for improvement of the treatment of advanced and metastatic cervical cancer, the rationale for combined chemo-immunotherapy. Anti-Cancer Agents Med. Chem. (Formerly Curr. Med. Chemistry-Anti-Cancer Agents). 14 (2), 190\u2013203 (2014).","journal-title":"Anti-Cancer Agents Med. Chem. (Formerly Curr. Med. Chemistry-Anti-Cancer Agents)"},{"issue":"9","key":"42656_CR12","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.3390\/vaccines10091452","volume":"10","author":"M Soumia","year":"2022","unstructured":"Soumia, M. et al. In-silico molecular modeling studies to identify novel potential inhibitors of HPV E6 protein. Vaccines 10 (9), 1452 (2022).","journal-title":"Vaccines"},{"key":"42656_CR13","doi-asserted-by":"publisher","first-page":"175","DOI":"10.12688\/openreseurope.17697.1","volume":"4","author":"M Zammit","year":"2024","unstructured":"Zammit, M. et al. A hospital-based survey assessing the health facility-level factors that contribute to delayed diagnosis of cervical cancer; patients views. Open. Res. Europe. 4, 175 (2024).","journal-title":"Open. Res. Europe"},{"issue":"13","key":"42656_CR14","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1200\/JCO.2010.28.2186","volume":"29","author":"K Hellner","year":"2011","unstructured":"Hellner, K. & M\u00fcnger, K. Human papillomaviruses as therapeutic targets in human cancer. J. Clin. Oncol. 29 (13), 1785\u20131794 (2011).","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"42656_CR15","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.3390\/cancers14102449","volume":"14","author":"Y Zhou","year":"2022","unstructured":"Zhou, Y. et al. Current standards in the management of early and locally advanced cervical cancer: update on the benefit of neoadjuvant\/adjuvant strategies. Cancers 14 (10), 2449 (2022).","journal-title":"Cancers"},{"key":"42656_CR16","doi-asserted-by":"crossref","unstructured":"Ranasinghe, V. & McMillan, N. Novel therapeutic strategies for targeting E6 and E7 oncoproteins in cervical cancer. Crit. Rev. Oncol. Hematol. 211, 104721 (2025).","DOI":"10.1016\/j.critrevonc.2025.104721"},{"issue":"2","key":"42656_CR17","doi-asserted-by":"publisher","first-page":"12003","DOI":"10.1080\/21655979.2021.2002494","volume":"12","author":"Y Zhou","year":"2021","unstructured":"Zhou, Y. et al. Rhophilin rho GTPase binding protein 1-antisense RNA 1 (RHPN1-AS1) promotes ovarian carcinogenesis by sponging microRNA-485-5p and releasing DNA topoisomerase II alpha (TOP2A). Bioengineered 12 (2), 12003\u201312022 (2021).","journal-title":"Bioengineered"},{"key":"42656_CR18","doi-asserted-by":"crossref","unstructured":"Smalley, T. B. et al. Targeted degradation of the HPV oncoprotein E6 reduces tumor burden in cervical cancer. Mol. Ther. 33(11), 5415\u20135426 (2025).","DOI":"10.1016\/j.ymthe.2025.08.033"},{"key":"42656_CR19","doi-asserted-by":"crossref","unstructured":"Carlos de Freitas, A., Campos, E., & Coimbra M. da Conceicao Gomes Leitao. Prospects of molecularly-targeted therapies for cervical cancer treatment. Current drug targets, 16(1): pp. 77\u201391. (2015).","DOI":"10.2174\/1389450116666141205150942"},{"key":"42656_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.canlet.2019.10.046","volume":"470","author":"M Celegato","year":"2020","unstructured":"Celegato, M. et al. A novel small-molecule inhibitor of the human papillomavirus E6-p53 interaction that reactivates p53 function and blocks cancer cells growth. Cancer Lett. 470, 115\u2013125 (2020).","journal-title":"Cancer Lett."},{"issue":"8","key":"42656_CR21","doi-asserted-by":"publisher","first-page":"3976","DOI":"10.1021\/acs.jcim.5c00023","volume":"65","author":"A Garg","year":"2025","unstructured":"Garg, A., Ramamurthi, N. & Das, S. S. Addressing Imbalanced Classification Problems in Drug Discovery and Development Using Random Forest, Support Vector Machine, AutoGluon-Tabular, and H2O AutoML. J. Chem. Inf. Model. 65 (8), 3976\u20133989 (2025).","journal-title":"J. Chem. Inf. Model."},{"issue":"1","key":"42656_CR22","doi-asserted-by":"publisher","first-page":"24906","DOI":"10.1038\/s41598-025-07574-6","volume":"15","author":"N Ali","year":"2025","unstructured":"Ali, N. et al. AI based natural inhibitor targeting RPS20 for colorectal cancer treatment using integrated computational approaches. Sci. Rep. 15 (1), 24906 (2025).","journal-title":"Sci. Rep."},{"issue":"8","key":"42656_CR23","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/s41589-024-01679-1","volume":"20","author":"DB Catacutan","year":"2024","unstructured":"Catacutan, D. B. et al. Machine learning in preclinical drug discovery. Nat. Chem. Biol. 20 (8), 960\u2013973 (2024).","journal-title":"Nat. Chem. Biol."},{"issue":"2","key":"42656_CR24","doi-asserted-by":"publisher","first-page":"164","DOI":"10.2174\/1574893616666210708143556","volume":"17","author":"Z Ye","year":"2022","unstructured":"Ye, Z. et al. Cervical cancer metastasis and recurrence risk prediction based on deep convolutional neural network. Curr. Bioinform. 17 (2), 164\u2013173 (2022).","journal-title":"Curr. Bioinform."},{"issue":"3","key":"42656_CR25","doi-asserted-by":"publisher","first-page":"e0213028","DOI":"10.1371\/journal.pone.0213028","volume":"14","author":"J Ricci-L\u00f3pez","year":"2019","unstructured":"Ricci-L\u00f3pez, J. et al. Molecular modeling simulation studies reveal new potential inhibitors against HPV E6 protein. PLoS One. 14 (3), e0213028 (2019).","journal-title":"PLoS One"},{"key":"42656_CR26","doi-asserted-by":"crossref","unstructured":"Ali, N., Asrar, B. & Ahmad, S. AI fragment based optimization of saffron and chamomile phytochemicals as aryl hydrocarbon receptor inhibitors for dementia therapy an integrated computational approach. Comput. Biol. Chem. 120, 108606 (2025).","DOI":"10.1016\/j.compbiolchem.2025.108606"},{"key":"42656_CR27","doi-asserted-by":"publisher","first-page":"126767","DOI":"10.1016\/j.molliq.2024.126767","volume":"419","author":"E Rahmanifar","year":"2025","unstructured":"Rahmanifar, E., Saheb, V. & Yoosefian, M. Carbon nanotube coated with tryptophan as a pH-sensitive nanocarrier in the delivery and smart release of the anticancer drug topotecan. J. Mol. Liq. 419, 126767 (2025).","journal-title":"J. Mol. Liq."},{"issue":"7","key":"42656_CR28","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1021\/cb500229d","volume":"9","author":"KA Malecka","year":"2014","unstructured":"Malecka, K. A. et al. Identification and characterization of small molecule human papillomavirus E6 inhibitors. ACS Chem. Biol. 9 (7), 1603\u20131612 (2014).","journal-title":"ACS Chem. Biol."},{"key":"42656_CR29","doi-asserted-by":"crossref","unstructured":"Vora, L. K. et al. Artificial intelligence in pharmaceutical technology and drug delivery design. Pharmaceutics, 15(7): p. 1916. (2023).","DOI":"10.3390\/pharmaceutics15071916"},{"issue":"9","key":"42656_CR30","doi-asserted-by":"publisher","first-page":"105051","DOI":"10.1016\/j.arabjc.2023.105051","volume":"16","author":"M Yoosefian","year":"2023","unstructured":"Yoosefian, M. et al. A suitable drug structure for interaction with SARS-CoV\u20102 main protease between boceprevir, masitinib and rupintrivir; a molecular dynamics study. Arab. J. Chem. 16 (9), 105051 (2023).","journal-title":"Arab. J. Chem."},{"issue":"1","key":"42656_CR31","doi-asserted-by":"publisher","first-page":"15906","DOI":"10.1038\/s41598-025-00937-z","volume":"15","author":"M Naveed","year":"2025","unstructured":"Naveed, M. et al. Exploring the therapeutic potential of Thymus vulgaris ethanol extract: a computational screening for antimicrobial compounds against COVID-19 induced mucormycosis. Sci. Rep. 15 (1), 15906 (2025).","journal-title":"Sci. Rep."},{"key":"42656_CR32","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/bs.pmbts.2024.03.030","volume":"205","author":"SK Ghandikota","year":"2024","unstructured":"Ghandikota, S. K. & Jegga, A. G. Application of artificial intelligence and machine learning in drug repurposing. Prog. Mol. Biol. Transl. Sci. 205, 171\u2013211 (2024).","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"issue":"20","key":"42656_CR33","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.2174\/1568026622666220701091339","volume":"22","author":"P Pasrija","year":"2022","unstructured":"Pasrija, P. et al. Machine learning and artificial intelligence: a paradigm shift in big data-driven drug design and discovery. Curr. Top. Med. Chem. 22 (20), 1692\u20131727 (2022).","journal-title":"Curr. Top. Med. Chem."},{"issue":"7","key":"42656_CR34","doi-asserted-by":"publisher","first-page":"649","DOI":"10.2174\/1568026621666210121153413","volume":"21","author":"DM Herrera-Ibat\u00e1","year":"2021","unstructured":"Herrera-Ibat\u00e1, D. M. Machine learning and perturbation theory machine learning (ptml) in medicinal chemistry, biotechnology, and nanotechnology. Curr. Top. Med. Chem. 21 (7), 649\u2013660 (2021).","journal-title":"Curr. Top. Med. Chem."},{"key":"42656_CR35","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman, L. Random forests. Mach. Learn. 45, 5\u201332 (2001).","journal-title":"Mach. Learn."},{"issue":"11","key":"42656_CR36","first-page":"607","volume":"4","author":"P Kaviani","year":"2017","unstructured":"Kaviani, P. & Dhotre, S. Short survey on naive bayes algorithm. Int. J. Adv. Eng. Res. Dev. 4 (11), 607\u2013611 (2017).","journal-title":"Int. J. Adv. Eng. Res. Dev."},{"key":"42656_CR37","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/9780470116449.ch6","volume":"23","author":"O Ivanciuc","year":"2007","unstructured":"Ivanciuc, O. Applications of support vector machines in chemistry. Rev. Comput. Chem. 23, 291 (2007).","journal-title":"Rev. Comput. Chem."},{"key":"42656_CR38","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1007\/s10462-020-09896-5","volume":"54","author":"C Bent\u00e9jac","year":"2021","unstructured":"Bent\u00e9jac, C., Cs\u00f6rg\u0151, A. & Mart\u00ednez-Mu\u00f1oz, G. A comparative analysis of gradient boosting algorithms. Artif. Intell. Rev. 54, 1937\u20131967 (2021).","journal-title":"Artif. Intell. Rev."},{"issue":"8","key":"42656_CR39","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3390\/ph14080741","volume":"14","author":"D Gomes","year":"2021","unstructured":"Gomes, D. et al. In silico approaches: a way to unveil novel therapeutic drugs for cervical cancer management. Pharmaceuticals 14 (8), 741 (2021).","journal-title":"Pharmaceuticals"},{"key":"42656_CR40","doi-asserted-by":"publisher","first-page":"138331","DOI":"10.1016\/j.molstruc.2024.138331","volume":"1308","author":"Z Yan","year":"2024","unstructured":"Yan, Z. et al. Synthesis, bioactivity evaluation and theoretical study of nicotinamide derivatives containing diphenyl ether fragments as potential succinate dehydrogenase inhibitors. J. Mol. Struct. 1308, 138331 (2024).","journal-title":"J. Mol. Struct."},{"issue":"7","key":"42656_CR41","doi-asserted-by":"publisher","first-page":"587","DOI":"10.4155\/fmc-2024-0007","volume":"16","author":"SE Biehn","year":"2024","unstructured":"Biehn, S. E. et al. BioPrint meets the AI age: development of artificial intelligence-based ADMET models for the drug-discovery platform SAFIRE. Future Med. Chem. 16 (7), 587\u2013599 (2024).","journal-title":"Future Med. Chem."},{"key":"42656_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13321-018-0283-x","volume":"10","author":"J Dong","year":"2018","unstructured":"Dong, J. et al. ADMETlab: a platform for systematic ADMET evaluation based on a comprehensively collected ADMET database. J. Cheminform. 10, 1\u201311 (2018).","journal-title":"J. Cheminform."},{"key":"42656_CR43","doi-asserted-by":"crossref","unstructured":"Banerjee, P. et al. ProTox 3.0: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Res. 52, W513\u2013W520 (2024).","DOI":"10.1093\/nar\/gkae303"},{"issue":"1","key":"42656_CR44","first-page":"2349","volume":"14","author":"J Dem\u0161ar","year":"2013","unstructured":"Dem\u0161ar, J. et al. Orange: data mining toolbox in Python. J. Mach. Learn. Res. 14 (1), 2349\u20132353 (2013).","journal-title":"J. Mach. Learn. Res."},{"key":"42656_CR45","unstructured":"Powers, D. M. Visualization of tradeoff in evaluation: from precision-recall & PN to LIFT, ROC & BIRD. arXiv preprint arXiv:1505.00401, 2015."},{"key":"42656_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13040-021-00244-z","volume":"14","author":"D Chicco","year":"2021","unstructured":"Chicco, D., T\u00f6tsch, N. & Jurman, G. The Matthews correlation coefficient (MCC) is more reliable than balanced accuracy, bookmaker informedness, and markedness in two-class confusion matrix evaluation. BioData Min. 14, 1\u201322 (2021).","journal-title":"BioData Min."},{"key":"42656_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.comptc.2011.12.002","volume":"983","author":"H Raissi","year":"2012","unstructured":"Raissi, H., Yoosefian, M. & Khoshkhou, S. Conformational study of the (z)-[(2-iminoethylidone) silyl] amine at the MP2, DFT and G2MP2 levels. Comput. Theor. Chem. 983, 1\u20136 (2012).","journal-title":"Comput. Theor. Chem."},{"key":"42656_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00339-021-04402-2","volume":"127","author":"H Sargazi-Avval","year":"2021","unstructured":"Sargazi-Avval, H. et al. Potential applications of armchair, zigzag, and chiral boron nitride nanotubes as a drug delivery system: Letrozole anticancer drug encapsulation. Appl. Phys. A. 127, 1\u20137 (2021).","journal-title":"Appl. Phys. A"},{"key":"42656_CR49","doi-asserted-by":"crossref","unstructured":"Yavuz, S. \u00c7. Quantum Chemical Computations, Molecular Docking, and ADMET Predictions of Cynarin. Bitlis Eren \u00dcniversitesi Fen Bilimleri Dergisi 13(2), 460\u2013466  (2024).","DOI":"10.17798\/bitlisfen.1425717"},{"key":"42656_CR50","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.molstruc.2019.02.071","volume":"1185","author":"W Xie","year":"2019","unstructured":"Xie, W. et al. 3D-QSAR and molecular docking studies of aminopyrimidine derivatives as novel three-targeted Lck\/Src\/KDR inhibitors. J. Mol. Struct. 1185, 240\u2013258 (2019).","journal-title":"J. Mol. Struct."},{"key":"42656_CR51","doi-asserted-by":"crossref","unstructured":"Wang, L. et al. Design and implementation of parallel lamarckian genetic algorithm for automated docking of molecules. In: 10th IEEE International Conference on High Performance Computing and Communications. 2008. IEEE. (2008).","DOI":"10.1109\/HPCC.2008.50"},{"issue":"1","key":"42656_CR52","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/imm.13793","volume":"173","author":"ZB Wang","year":"2024","unstructured":"Wang, Z. B. et al. Immunotherapy and the ovarian cancer microenvironment: Exploring potential strategies for enhanced treatment efficacy. Immunology 173 (1), 14\u201332 (2024).","journal-title":"Immunology"},{"issue":"36","key":"42656_CR53","doi-asserted-by":"publisher","first-page":"10701","DOI":"10.1002\/slct.201902105","volume":"4","author":"A Kumar","year":"2019","unstructured":"Kumar, A., Rathi, E. & Kini, S. G. Identification of E6 inhibitors employing energetically optimized structure-based pharmacophore modelling, ligand docking and molecular dynamics simulations studies. ChemistrySelect 4 (36), 10701\u201310708 (2019).","journal-title":"ChemistrySelect"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42656-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42656-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42656-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T01:02:21Z","timestamp":1780534941000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42656-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["42656"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-42656-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"assertion":[{"value":"8 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of human and animal rights"}},{"value":"All molecular structures, descriptors, and activity data used in this study are provided in the Supporting Information.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data and software availability"}}],"article-number":"17272"}}